Goldman Sachs downgrades Edwards Lifesciences (NYSE: EW) from Conviction Buy List to Neutral citing a less attractive risk/reward. The firm ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE